What’s Next? Five Things To Look Out For In August
Coherus’ Ranibizumab Date And Key Biocon Biosimilar Inspections Feature
A busy August brings patent expiries, biosimilar target action dates and the potential for a major change to biosimilar prescribing guidelines in Germany.
